Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Total Debt (2016)

Historic Total Debt for KalVista Pharmaceuticals (KALV) over the last 3 years, with Q1 2016 value amounting to $4.7 million.

  • KalVista Pharmaceuticals' Total Debt rose 384.01% to $4.7 million in Q1 2016 from the same period last year, while for Mar 2016 it was $4.7 million, marking a year-over-year increase of 384.01%. This contributed to the annual value of $127000.0 for FY2016, which is N/A changed from last year.
  • KalVista Pharmaceuticals' Total Debt amounted to $4.7 million in Q1 2016, which was up 384.01% from $4.6 million recorded in Q4 2015.
  • In the past 5 years, KalVista Pharmaceuticals' Total Debt ranged from a high of $4.7 million in Q1 2016 and a low of $4.4 million during Q4 2014
  • Over the past 3 years, KalVista Pharmaceuticals' median Total Debt value was $4.5 million (recorded in 2015), while the average stood at $4.5 million.
  • In the last 5 years, KalVista Pharmaceuticals' Total Debt soared by 392.33% in 2015 and then soared by 384.01% in 2016.
  • KalVista Pharmaceuticals' Total Debt (Quarter) stood at $4.4 million in 2014, then grew by 3.92% to $4.6 million in 2015, then rose by 0.91% to $4.7 million in 2016.
  • Its last three reported values are $4.7 million in Q1 2016, $4.6 million for Q4 2015, and $4.6 million during Q3 2015.